The bad news from AbbVie’s full year results was that inflammatory diseases blockbuster Humira “only” made ... already got off to a good start – psoriasis drug Skyrizi pulled in a ...

BE SURE is a phase 3, randomised, double-blind study comparing bimekizumab to Humira in adult patients with moderate-to-severe chronic plaque psoriasis ... give it a cash injection to plough ...

Plaque psoriasis is an autoimmune disease ... and ulcerative colitis. Both drugs are injections, but you'll take Humira once ...

Psoriasis: Adalimumab Biosimilars Comparable With Originator Biosimilars show comparable safety with Humira among new users with psoriasis in a multinational cohort study, but discontinuations ...

Humira has been a blockbuster worldwide for nearly two decades. The biologic has multiple indications, including rheumatoid arthritis, Crohn’s disease and psoriasis. The Foundation asserts that ...

The injection is given in the thigh or abdomen ... If you are using this medication to treat psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, or uveitis, your doctor ...

Yesterday, Amgen announced that it would launch the U.S.’s first marketed Humira-referenced biosimilar, Amjevita (adalimumab-atto), at two different list prices: $3,288 and $1,557 per 40 mg pen ...